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Objective: Most previous reports on intramural hematoma of the aorta have focused
on the initial episode. The purpose of this study was to clarify the long-term
outcome of intramural hematoma of the aorta.
Methods: Ninety-four cases of intramural hematoma of the aorta (41 type A and 53
type B) were reviewed. There were 69 male and 25 female patients, and their mean
age was 66.7  8.7 years (range, 46-88 years).
Results: Eleven (27%) of the patients with type A hematoma and 1 (2%) of the
patients with type B hematoma underwent early surgical intervention. Others were
treated medically, and the overall hospital mortality was 7% for patients with type
versus 2% for patients with type B intramural hematomas of the aorta (P  .315).
Twenty-three patients, 9 (22%) with type A and 14 (26%) with type B intramural
hematomas of the aorta, underwent late surgical intervention during the follow-up
period, and there were no hospital deaths. A total of 23 patients died during the
follow-up period, including 6 of intramural hematoma of the aorta–related deaths (3
in the type A group and 3 in the type B group). The estimated freedom from
intramural hematoma of the aorta–related events at 1 and 5 years was 70%  8%
and 54% 11% for the type A group versus 73% 6% and 58% 8% for the type
B group, respectively (P  .972). After excluding the nonintramural hematoma of
the aorta–related deaths, the survival rates at 5 and 10 years were 80%  9% and
80%  9% for the type A group and 91%  8% and 81%  11% for the type B
group (P  .211).
Conclusions: Intramural hematoma of the aorta–related events occur equally in both
types of intramural hematoma of the aorta. We recommend close follow-up for at
least 5 years because most intramural hematoma of the aorta–related events occur
during this period.
Recent advances in diagnostic modalities have enabled rapid anddefinitive diagnosis of intramural hematoma of the aorta (IMH),1-4and although voluminous data on IMH have been accumulated asa result, most investigators have focused on the initial presentingepisode and its management. Type B IMH is currently consideredto be less severe, and medical treatment is considered appropriate.5
In 1993, Robbins and associates1 recommended that early surgical intervention be
considered for all patients with type A IMH, and their recommendation was widely
accepted in Western countries.4,5 Conversely, we reported that emergency surgery
was reasonable in 27% of selected patients out of 33 with type A IMH, and that 50%
could be managed with medical treatment alone.3
In view of the pathophysiologic process in IMH, the absence of flow and pressure
communication with the aortic lumen might produce good results.6 By contrast, as
Sundt7 pointed out, IMH is fundamentally a disease of the media, and thus the
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behavior of IMH is of great concern. Until now, little
information has been available on the midterm to long-term
outcome of IMH,8 and several questions remain. Is it true
that type B IMH is less serious throughout the entire fol-
low-up period? What is the behavior of IMH over time, and
are there any differences between type A and type B IMH?
Are there any predictive factors for progression of IMH?
How should patients with IMH be managed on the basis of
the clinical evidence?
The purpose of the present study was to clarify the
clinical features and to determine the long-term outcome of
type A and type B IMH by retrospectively reviewing 94
cases.
Patient Population and Methods
From January 1990 through December 2002, a total of 233 patients
were referred to Sendai City Medical Center with acute aortic
dissection variables. Ninety-four (40%) of these patients were
given a diagnosis of IMH. There were 69 male and 25 female
patients with a mean age of 66.7  8.7 years (range, 46-88 years).
The diagnostic criteria for IMH were previously reported3: (1)
symptoms such as severe chest or back pain like that of acute
aortic dissection and (2) initial computed tomographic (CT) ex-
amination performed within 24 hours from the onset of symptoms
showing the characteristic findings presented by Yamada and
colleagues.9 Furthermore, the diagnosis was confirmed through
operative findings or serial CT examinations.
Management
Initial management of IMH was the same, in principal, whether
type A or type B IMH was found: only patients with cardiac
tamponade, impending rupture, or rupture underwent surgical in-
tervention on an emergency basis; others were treated medically,
with intensive antihypertensive therapy in the intensive care unit,
for a couple of days. Details of medical treatment are described
elsewhere.3 After discharge, all patients were followed as outpa-
tients, having resumed their previous lifestyles. Patients with med-
ical treatment converted to surgical treatment in the following
cases: (1) recurrence of chest or back pain suggestive of impending
rupture; (2) progression to overt type A dissection; (3) progressive
aortic dilatation to more than 60 mm in maximum diameter; or (4)
progressive enlargement of the ulcer-like projection (ULP)10 to
more than 20 mm in diameter or depth.
CT Examinations
CT images were obtained at 3- to 10-mm intervals from the top of
the aortic arch to the aortic bifurcation, with and without contrast
medium. Initial CT scans were performed within 24 hours from
episode onset in all patients. For medically treated patients, serial
CT examinations were performed at 2 and 4 weeks after admis-
sion; at 3, 6, and 12 months after discharge; and once a year
thereafter. For patients undergoing surgical intervention, follow-up
CT scans were performed at discharge and then once a year. The
external diameter and wall thickness of the ascending and descend-
ing aorta were measured in each slice, and the aortic arch was
measured as described by Sueyoshi and coworkers.11 In type B
IMH the maximum aortic diameter and wall thickness were rep-
resented by the largest external dimension and wall thickness in
the aortic arch or descending aorta.
Follow-up was obtained in all but 2 patients (98%) by means of
direct or telephone contact, communication with the primary phy-
sician, or both. The cumulative follow-up period was 415 patient-
years (mean, 52.9  39.4 months; range, 0-156 months).
Clinical features, hospital mortality, long-term survivals, and
freedom from IMH-related events were compared between pa-
tients with type A and type B IMH. IMH-related events were
defined as follows: (1) satisfaction of criteria for surgical conver-
sion (with or without actual surgical intervention); (2) death from
aortic rupture; (3) sudden unexplained death; and (4) progression
to overt type B dissection. Furthermore, clinical characteristics and
CT images were analyzed to identify predictors of IMH-related
events for patients with type B IMH (Appendix).
Statistical Analysis
A software package (StatView 5.0 for Macintosh; SAS Inc, Cary,
NC) was used for statistical analyses. Data are presented as means
and SDs. Comparisons between type A and type B IMH were
made by using the Mann-Whitney U test for continuous variables.
Discrete variables were treated by means of contingency tables and
analyzed by using the Fisher exact test. One-, 3-, 5-, and 10-year
freedoms from IMH-related events and actuarial survivals were
estimated by using the Kaplan-Meier method and compared with
log-rank tests. Each estimate was expressed as the mean  SEM.
The Cox proportional hazards model was used to identify the
predictors of IMH-related events throughout the entire follow-up
period by using univariate and forward stepwise Cox regression
analysis (with entry and removal thresholds of 0.05 and 0.1,
respectively).
Results
Among the 94 patients, 41 had type A and 53 had type B
IMH. The mean ages of patients with type A and type B
IMH were 67.0 9.1 years (range, 46-88 years) and 66.5
8.5 years (range, 48-84 years), respectively (P  .789).
Male patients were more predominant in the type B group
(85%) than in the type A group (59%, P  .0051). Hyper-
tension was the most common risk factor, being associated
with 32 (78%) patients with type A IMH and 47 (87%)
patients with type B IMH (P  .256). IMH-related compli-
cations were more frequent in type A than in type B IMH.
Twelve (29%) patients with type A IMH but only 1 (2%)
patient with type B IMH were in shock on admission (P 
.0001). Cardiac tamponade occurred in 10 (24%) and aortic
rupture in 4 (10%) patients with type A IMH, whereas aortic
rupture alone occurred in only 1 patient with type B IMH.
Hemiplegia occurred in 2 patients with type A IMH, but the
symptoms were transient and improved after surgical inter-
vention. Paraplegia occurred in 1 patient with type A IMH,
the details of which were previously reported.12
Eleven (27%) of 41 patients with type A IMH underwent
early surgical intervention with a diagnosis of cardiac tam-
ponade (n  9) or rupture (n  2). Total arch replacement
was carried out in 3 patients, and ascending aorta replace-
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ment was done in 8 patients. Two of 11 patients were lost
postoperatively; one died of low-output syndrome and the
other of severe brain damage produced by deterioration of
old cerebral infarction. Despite association of cardiac tam-
ponade or rupture, 3 patients with type A IMH did not
undergo early surgical intervention; 2 of these patients
refused the operation and were treated medically, whereas
another, in whom IMH was completely absorbed within a
day, received medical treatment.13 Meanwhile, only 1 (2%)
patient with type B IMH underwent early surgical interven-
tion, with a diagnosis of aortic rupture. Eighty-two (87%)
patients were initially treated medically. Five (5%) patients
required mechanical ventilation and sedation to maintain
blood pressure at an appropriate level. One patient with type
B IMH died of descending thoracic aortic rupture 2 days
after admission. Another patient with type A IMH died of
sepsis resulting from an associated liver abscess. Four of the
94 patients died (3 with type A IMH and 1 with type B
IMH) during the first admission, and the overall hospitality
mortality was 7% in patients with type A IMH and 2% in
patients with type B IMH (P  .315).
Twenty-three of the 82 patients who were initially
treated medically underwent surgical intervention during
the follow-up period: 9 (22%) of these patients had type A
IMH, and 14 (26%) had type B IMH. Progression to overt
type A dissection was the most common reason for surgical
conversion in patients with type A IMH, and this occurred
in 6 patients. In patients with type B IMH, progressive
dilatation of the aorta and enlargement of the ULP were the
major reasons for conversion and were seen in 5 and 9
patients, respectively. The interval between the onset of
IMH and surgical conversion varied according to the cause
of conversion to surgical intervention. For example, when
operations were performed because of progression to overt
type A dissection, the interval was 3.9 2.0 months (range,
2-6 months). Moreover, when enlargement of ULP neces-
sitated surgical intervention, the interval was 2.1  0.88
months (range, 1-4 months). Conversely, when progressive
dilatation of the aorta brought about surgical conversion, the
interval was much longer: 23.2  19.0 months (range, 3-49
months). Practical procedures for these lesions were varied
and are listed in Table 1. There were no hospital deaths
among these 23 patients. Twenty-one (51%) patients with
type A IMH and 38 (72%) patients with type B IMH were
given medical treatment alone during the entire follow-up
period.
A total of 23 patients died during the follow-up period.
Six patients (3 with type A IMH and 3 with type B IMH)
died of aortic rupture or sudden unexplained death, which
were considered to be IMH-related deaths. Although 2 of
these 6 patients had received graft replacement previously
(ascending plus arch replacement in type A IMH and de-
scending aortic replacement in type B IMH), ruptures oc-
curred at the remaining descending thoracic aorta. In 5 of
these 6 patients, marked dilatation of the descending tho-
racic aorta was detected before death. Two patients refused
surgical intervention, and 1 patient, who was bedridden
because of stroke, was judged to be beyond surgical indi-
cation. Another 2 patients were followed as outpatients
because the maximum diameter of the descending aorta was
less than 60 mm. The mean interval from onset of IMH to
death was 53.8 months (median, 49 months; range, 18-111
months). Seventeen other cases resulted in non–IMH-re-
lated death, and the major causes of death were cerebrovas-
cular disease and malignancy, occurring in 3 and 2 patients
with type A IMH versus 2 and 3 in patients with type B
IMH, respectively. The causes of death are listed in Table 2.
The clinical course of the patients with IMH is presented as
a visual flow chart in Figure 1.
The estimates of freedom from IMH-related events at 1,
3, 5, and 10 years were 70%  8%, 66%  9%, 54% 
11%, and 54%  11% for type A IMH versus 73%  6%,
68%  7%, 58%  8%, and 51%  9% for type B IMH (P
 .972, Figure 2). Including hospital deaths, the cumulative
1-, 3-, 5-, and 10-year survivals were 90%  5%, 81% 
7%, 55%  12%, and 44%  14% in patients with type A
IMH versus 94%  3%, 92%  4%, 73%  8%, and 50%
 10% in patients with type B IMH (P  .219, Figure 3).
Excluding non–IMH-related deaths, the 1-, 3-, 5-, and 10-
year survivals were 95%  3%, 92%  4%, 80%  9%,
and 80%  9% in patients with type A IMH versus 98% 
2%, 98%  2%, 91%  8%, and 81%  11% in patients
with type B IMH (P  .211, Figure 4).
Clinical profiles and CT examinations were evaluated as
predictors for IMH-related events in patients with type B
TABLE 1. Practical procedures and cause of surgical con-
version in type A and type B IMH
Type A IMH Type B IMH
Progression to type A dissection
Ascending 4 0
Ascending  arch  AVR 1 0
Progression to type B dissection
Descending 0 1
Progression to type A  B dissection
Ascending  descending 1 0
Enlargement of ulcer-like projection
Descending 0 7
Thoracoabdominal 0 1
Stent (at descending) 1 0
Impending rupture
Descending 1 0
Dilatation of thoracic aorta
Ascending  arch 1 0
Arch  descending 0 4
Thoracoabdominal 0 1
Total 9 14
AVR, Aortic valve replacement.
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IMH. Hypertension (P  .0046) and the maximum wall
thickness at 2 to 4 weeks after admission (P  .0017) were
significantly correlated variables for IMH-related events
because of enlargement of the ULP or overt type B dissec-
tion. Multivariate analysis revealed that the maximum wall
thickness at 2 to 4 weeks after admission was the only
predictor (hazard ratio, 1.222; 95% confidence interval,
1.049-1.425; P  .01). Furthermore, we calculated an op-
timal cutoff value of 16 mm, resulting in positive and
negative predictive values of 60% and 86%, respectively.
On the other hand, the maximum external diameter on
admission (P .001) and 2 to 4 weeks later (P .005) was
also a significantly correlated variable for IMH-related
events because of progressive aortic dilatation or rupture.
Multivariate analysis revealed that the maximum external
diameter on admission was a predictor (hazard ratio, 1.250;
95% confidence interval, 1.01-1.547; P  .04), with an
optimal cutoff value of 53 mm and positive and negative
predictive values of 100% and 96%, respectively (Tables 3
and 4).
Discussion
IMH develops as a result of spontaneous rupture of the vasa
vasorum of the aorta14 or rupture of an atherosclerotic
plaque,1 and it is considered a unique entity in aortic pa-
thology. Although it is well known that IMH might progress
or regress with time, assessment of progression or regres-
sion of IMH includes difficult problems, such as the timing
of the evaluation (eg, 1 month, 1 year, and later) and the
method of evaluation (clinical or radiologic). Thus on the
basis of the clinical and radiologic evidence throughout the
follow-up period, we substituted IMH-related events (or
freedom therefrom) for progression (or regression) of IMH.
In this article IMH-related events are defined as satisfaction
of surgical conversion criteria or IMH-related death. It is
noteworthy that the IMH-related event-free curve rapidly
decreased to about 70% within 6 months and then gradually
decreased to around 50% during the next 5 years, with no
difference between types A and B. This means that the
nature of subsequent IMH-related events is variable and
depends on the interval between the onset of IMH and the
IMH-related event, with progression to overt dissection and
progressive dilatation of the ULP, both of which are con-
sidered to be caused by intimal disruption, accounting for
most of the IMH-related events within the first 6 months. In
fact, all conversions to surgical treatment because of overt
type A dissection or enlargement of the ULP occurred
within 6 months. On the other hand, progressive aortic
dilatation or aortic rupture (resulting from enlargement of
the aorta without intimal disruption) accounted for most
IMH-related events that occurred in both types of IMH after
more than 1 year. The mean interval from onset of IMH to
conversion to surgical intervention because of progressive
dilatation was about 2 years, and the mean interval to death
from aortic rupture was about 4 to 5 years. These results
suggest that a variety of processes might be involved in the
progression of IMH and that serial follow-up examinations
are necessary for at least 5 years.
There have been some reports on predictive factors for
the progression of type A or type B IMH. Kaji and cowork-
ers2 claimed that the maximum aortic diameter on the initial
CT images was the only significant predictor of progression
of type A IMH, with a cutoff value of 50 mm, whereas
Nishigami and associates15 reported that the maximum aor-
tic diameter of less than 45 mm suggests a good prognosis
of both type A and type B IMH. Sueyoshi and colleagues11
recently reported that the maximum aortic diameter and
wall thickness are predictors of progression of type B IMH,
with optimal cutoff values of 40 mm and 10 mm, respec-
tively. Although all of these studies found that maximum
aortic diameter or wall thickness was closely related to the
progression of IMH, their definitions of progression varied
and included an increase in aortic diameter or wall thick-
ness, aortic dissection, and death as a result of rupture.
Because the nature of subsequent IMH-related events is
variable and depends on the interval between the onset of
IMH and the IMH-related event, it seemed unreasonable to
lump diverse forms of progression under one name and then
try to identify the predictors. In view of this, we have
estimated the predictors of each IMH-related event indepen-
dently. We previously reported that the only significant
predictor of progression to overt type A dissection within 4
weeks was wall thickness at 2 weeks after admission,3 and
in this article we defined 2 predictors in type B IMH:
maximum wall thickness at 2 to 4 weeks after admission
(for IMH-related events caused by enlargement of the ULP
or overt type B dissection) and maximum aortic diameter on
admission (for IMH-related events caused by progressive
aortic dilatation or rupture). These findings seem obvious in
a sense. A certain volume of hematoma in the aortic wall
might cause the intima to become fragile and lead to
intimal disruption. This might explain why wall thickness
is related to progression to overt dissection or ULP. On
TABLE 2. Causes of the late death
Type A IMH Type B IMH Total
Aortic rupture 2 3 5
Cerebrovascular disease 3 2 5
Malignancy 2 3 5
Myocardial infarction 0 2 2
Pneumonia 0 2 2
Renal failure 1 0 1
Anorexia nervosa 0 1 1
Sudden unexplained death 1 0 1
Accident 0 1 1
Total 9 14 23
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the other hand, as Laplace’s law indicates, the affected
aorta is far easier to dilate in proportion to its diameter.
This might also account for the relationship between
aortic diameter and progressive aortic dilatation or rup-
ture, and the growth rate has actually been reported to be
0.4 to 0.75 cm/y.8,11
Figure 1. Flow chart of clinical course and outcomes.
Figure 2. Freedom from IMH-related events.
Figure 3. Cumulative survival curve.
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How should the patient with IMH be managed on the
basis of clinical evidence? After the recommendation of
Robbins and associates,1 early surgical intervention for type
A IMH was widely adopted in the West and became anec-
dotal, without verification by clinical evidence in a large
series of cases. O’Gara and DeSanctis5 asserted that IMH
should be managed according to the same guidelines as
classic dissection; that is, if unassociated with serious com-
plications, type B IMH should be managed medically, like
classic type B dissection, but type A IMH requires urgent
surgical repair. On the basis of the midterm follow-up of
IMH, Tittle and associates8 have recommended surgical
repair regardless of the lesion involved because of the high
early rupture rate and the documented occurrence of late
rupture. Our results do not necessarily support their recom-
mendations. As stated above, we found that early surgical
intervention is indispensable in around 30% of patients with
type A IMH and 2% of patients with type B IMH but that
about 50% of patients with type A IMH and 70% of patients
with type B IMH could be managed medically alone. More-
over, all late ruptures occurred in the descending aorta, and
5 of the 9 patients whose treatment was converted to sur-
gical intervention required arch or descending aortic proce-
dures, even for type A IMH. Accordingly, patient selection
is primary and prophylactic surgical intervention, which can
reduce the risk of death and shorten the hospital stay and
can be used to extract anticipated patients. Indeed, after
identifying a predictor of progression to type A dissection,
we decided to perform prophylactic ascending aortic re-
placement in patients with type A IMH with a wall thick-
ness of greater than 12 mm. As predictors of other IMH-
related events (progressive aortic dilatation or fatal rupture)
have not yet been determined to be predictors of type A
IMH, serial CT examinations are necessary to avoid missing
the opportunity for surgical treatment. IMH-related events
also occurred during the follow-up period in about 50% of
patients with type B IMH. Although predictors of IMH-
related events in patients with type B IMH have been
identified, they are not always available in practice. Because
it is always difficult to accurately forecast the location of the
ULP or the extent of dilatation of the aorta at the time of the
first admission, prophylactic procedures should not be done
at random. Under these circumstances, closed and serial
imaging examinations are of overriding importance.
By taking appropriate measures, we managed patients
with type A or type B IMH by using common criteria. The
result was no significant difference between patients with
type A and type B IMH in hospital mortality; in 1-, 3-, 5-,
or 10-year cumulative survival; or in actuarial freedom from
IMH-related events. The cumulative survival showed a
downward trend after 5 years and decreased to less than
50% at 10 years, but this seemed to reflect the advanced age
of the patients with IMH. After excluding non–IMH-related
deaths, the 10-year survivals in both types of IMH remained
greater than 80%.
Figure 4. Survival curve excluding non–IMH-related death.
TABLE 3. The results of CT examinations
IMH-related events Yes No
P
value
Enlargement of ULP or overt type B
dissection
Maximum aortic diameter on
admission (mm)
40.7 2.6 42.6 7.1 .406
Maximum aortic diameter after
2–4 wk (mm)
43.3 5.4 41.4 6.4 .397
Wall thickness on admission (mm) 14.4 4.7 11.8 4.6 .115
Wall thickness after 2–4 wk (mm) 14.3 4.0 8.5 4.6 .001
Progressive aortic dilatation or
rupture
Maximum aortic diameter on
admission (mm)
52.0 9.9 41.1 5.0 .0001
Maximum aortic diameter after
2–4 wk (mm)
51.0 6.8 40.8 5.4 .0002
Wall thickness on admission (mm) 13.6 7.7 12.2 4.4 .520
Wall thickness after 2–4 wk (mm) 11.2 5.3 9.5 5.3 .490
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Finally, 2 special points should be emphasized. First, 2
patients died of aortic rupture despite having a maximum
aortic diameter of less than 60 mm just before death. This
indicates that the appropriate size criterion for surgical
repair should be reconsidered. Second, 2 other patients died
of aortic rupture in spite of a previous graft replacement,
indicating that surgical intervention cannot completely pre-
vent late rupture and that serial CT examinations are nec-
essary, even after an operation.
Conclusions
IMH-related events occur over time in about 50% of pa-
tients with IMH, and most of them occur within 5 years.
Although predictors of IMH-related events in type B IMH
have been identified, it is difficult to forecast the location of
the ULP or the extent of dilatation of the aorta, and closed
and serial CT examinations are of overriding importance.
After excluding non–IMH-related deaths, the 5- and 10-year
survivals in patients with both types of IMH remained
greater than 80%. By taking appropriate measures, IMH,
regardless of location, can be managed on the basis of
uniform criteria.
We thank Mr Takenobu Tasaki for valuable help with statistical
analysis.
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Appendix
Clinical characteristics and CT image variables
analyzed.
Sex
Age
Diabetes mellitus
Hypertension
Hyperlipidemia
Maximum external diameter on admission
Maximum external diameter at 2 to 4 weeks after admission
Maximum wall thickness on admission
Maximum wall thickness at 2 to 4 weeks after admission
TABLE 4. Results of univariate and multivariate analysis for progression of IMH in type B IMH
Variable
Univariate Multivariate
2 P value Hazard ratio 95% confidence interval P value
Enlargement of ULP or overt dissection
Hypertension 8.050 .0046 3.003 0.681–13.24 .146
CT examination 2–4 wk later
Maximum diameter 0.651 .420
Wall thickness 9.852 .0017 1.222 1.049–1.425 .010
Aortic dilatation or rupture
CT examination on admission
Maximum diameter 10.308 .0013 1.250 1.01–1.547 .040
Wall thickness 0.849 .357
CT examination 2–4 wk later
Maximum diameter 8.058 .005 1.103 0.917–1.327 .297
Wall thickness 0.012 .913
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